664 related articles for article (PubMed ID: 14633322)
1. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
2. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
Halperin JL
J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
[TBL] [Abstract][Full Text] [Related]
3. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
4. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
5. Ximelagatran.
Choudhury A; Goyal D; Lip GY
Drugs Today (Barc); 2006 Jan; 42(1):3-19. PubMed ID: 16511607
[TBL] [Abstract][Full Text] [Related]
6. Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.
McCullough PA; Dorrell KA; Sandberg KR; Yerkey MW
Rev Cardiovasc Med; 2004; 5(2):99-103. PubMed ID: 15184843
[TBL] [Abstract][Full Text] [Related]
7. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
8. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
Scardi S; Giansante C
Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
[TBL] [Abstract][Full Text] [Related]
9. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
10. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials.
Albers GW;
Am J Manag Care; 2004 Dec; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910
[TBL] [Abstract][Full Text] [Related]
11. Ximelagatran for stroke prevention in atrial fibrillation.
Boos CJ; Lip GY
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):551-63. PubMed ID: 16076267
[TBL] [Abstract][Full Text] [Related]
12. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
13. New possibilities in anticoagulant management of atrial fibrillation.
Waldo AL
Rev Cardiovasc Med; 2004; 5 Suppl 5():S30-8. PubMed ID: 15619613
[TBL] [Abstract][Full Text] [Related]
14. Ximelagatran in prevention of cardiovascular events.
Molckovsky D; Boucher M
Issues Emerg Health Technol; 2004 Nov; (62):1-4. PubMed ID: 15565751
[TBL] [Abstract][Full Text] [Related]
15. Orally active direct thrombin inhibitors.
Weitz J
Semin Vasc Med; 2003 May; 3(2):131-8. PubMed ID: 15199476
[TBL] [Abstract][Full Text] [Related]
16. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
[TBL] [Abstract][Full Text] [Related]
17. Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.
Harenberg J; Ingrid J; Tivadar F
Isr Med Assoc J; 2002 Nov; 4(11):1003-5. PubMed ID: 12489490
[TBL] [Abstract][Full Text] [Related]
18. Ximelagatran for prevention and treatment of venous thromboembolism.
Kwok L; Boucher M
Issues Emerg Health Technol; 2004 Jun; (57):1-4. PubMed ID: 15214359
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
[TBL] [Abstract][Full Text] [Related]
20. Preventing stroke in atrial fibrillation: the SPORTIF programme.
Lip GY
Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():25-30. PubMed ID: 15812201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
